lisofylline has been researched along with verapamil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obruśnik, A; Pekala, E; Szymura-Oleksiak, J; Wyska, E | 1 |
| Wyska, E | 2 |
3 other study(ies) available for lisofylline and verapamil
| Article | Year |
|---|---|
Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Area Under Curve; Biological Transport; Hematologic Agents; Injections, Intravenous; Intestinal Absorption; Ketoconazole; Male; Mice; Models, Biological; Pentoxifylline; Verapamil | 2007 |
Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock.
Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytokines; Drug Synergism; Lipopolysaccharides; Liver; Lung; Male; Mice; Pentoxifylline; Prednisolone; Shock, Septic; Verapamil | 2009 |
Pharmacokinetic interaction between verapamil and methylxanthine derivatives in mice.
Topics: Adjuvants, Immunologic; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Male; Mice; Mice, Knockout; Pentoxifylline; Tissue Distribution; Vasodilator Agents; Verapamil | 2010 |